No specific treatment or vaccine for the virus is commercially available. Efforts to help those who are infected are supportive; they include either oral rehydration therapy (drinking slightly sweetened and salty water) or giving intravenous fluids as well as treating symptoms. This supportive care improves outcomes. EVD was first identified in 1976 in an area of Sudan (now part of South Sudan), and in Zaire (now the Democratic Republic of the Congo). The disease typically occurs in outbreaks in tropical regions of sub-Saharan Africa.[1] Through 2013, the World Health Organization reported a total of 1,716 cases in 24 outbreaks. The largest outbreak to date is the ongoing epidemic in West Africa, which is centered in Guinea, Sierra Leone and Liberia.As of 4 November 2014, this outbreak has 13,592 reported cases resulting in 5,408 deaths.